Important investment information and business conditions such as general meetings and settlements.
Innovative drug products with Samyang’s proprietary Drug Delivery Systems Technology are manufactured at advanced GMP facilities
Recognized as the No.1 company in the surgical suture materials, that consistently exports first-class quality products worldwide, we are expanding our portfolio of diverse medical device products that utilize bio-absorbable materials.
Each year 20-30% of sales is re-invested in research securing a diverse range of core technologies to advance as a global research center for DDS technologies and biodegradable material medical devices.
Samyang Holdings Biopharmaceuticals Division has acquired a wide range of innovative technologies and will continue to actively pursue acquisition of technologies in promising fields with high growth potential.
Samyang Holdings Biopharmaceuticals Division focuses in developing new medical products and trends in advanced biodegradable base materials that will revolutionize medicine in the future.
Samyang Holdings Biopharmaceuticals Division pursues innovation through collaborative research and development with academic institutions and industry.
31 Jongno 33-gil, jongno-gu, Seoul TEL +82-2-740-7116 FAX +82-2-743-6626
Copylight ⓒ 2013 Samyang Biopharmaceuticals Corporation. All rights Reserved.
